Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-11-08

Clinical Trial Update: A Clinical Study to Evaluate the Drug Interaction Between YZJ-1139 Tablets and Escitalopram Oxalate Tablets [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update evaluating the drug interaction between YZJ-1139 tablets and escitalopram oxalate tablets for insomnia; the study is currently a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Escitalopram Oxalate Tablets (escitalopram oxalate)
  • YZJ-1139 Tablets (YZJ-1139)

Snippet

Sponsor: Shanghai Haiyan Pharmaceutical Technology Co., Ltd. | Conditions: Insomnia, Central Nervous System | Phase 1 | Status: ACTIVE_NOT_RECRUITING